Curt A. Dvorak

1.9k total citations
37 papers, 1.3k citations indexed

About

Curt A. Dvorak is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Curt A. Dvorak has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Organic Chemistry and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Curt A. Dvorak's work include Receptor Mechanisms and Signaling (10 papers), Mast cells and histamine (6 papers) and Neuropeptides and Animal Physiology (6 papers). Curt A. Dvorak is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Mast cells and histamine (6 papers) and Neuropeptides and Animal Physiology (6 papers). Curt A. Dvorak collaborates with scholars based in United States and Belgium. Curt A. Dvorak's co-authors include Nicholas I. Carruthers, Timothy W. Lovenberg, Viresh H. Rawal, Pascal Bonaventure, Steven W. Sutton, A. I. MEYERS, Sandy J. Wilson, Ann Barbier, Brian Lord and Leah Aluisio and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Curt A. Dvorak

37 papers receiving 1.3k citations

Peers

Curt A. Dvorak
Michael A. Letavic United States
Jamin D. Boggs United States
Peter A. Boxer United States
Sigurd Elz Germany
Samuel Hintermann Switzerland
Hyo Jin Son South Korea
Michael A. Letavic United States
Curt A. Dvorak
Citations per year, relative to Curt A. Dvorak Curt A. Dvorak (= 1×) peers Michael A. Letavic

Countries citing papers authored by Curt A. Dvorak

Since Specialization
Citations

This map shows the geographic impact of Curt A. Dvorak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curt A. Dvorak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curt A. Dvorak more than expected).

Fields of papers citing papers by Curt A. Dvorak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curt A. Dvorak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curt A. Dvorak. The network helps show where Curt A. Dvorak may publish in the future.

Co-authorship network of co-authors of Curt A. Dvorak

This figure shows the co-authorship network connecting the top 25 collaborators of Curt A. Dvorak. A scholar is included among the top collaborators of Curt A. Dvorak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curt A. Dvorak. Curt A. Dvorak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gelin, Christine F., Heather Coate, Brian Lord, et al.. (2023). Discovery of a Series of Substituted 1H-((1,2,3-Triazol-4-yl)methoxy)pyrimidines as Brain Penetrants and Potent GluN2B-Selective Negative Allosteric Modulators. Journal of Medicinal Chemistry. 66(4). 2877–2892. 3 indexed citations
2.
Dvorak, Curt A., Diane Nepomuceno, Lisa Dvorak, et al.. (2020). Discovery and SAR studies of 2-alkyl-3-phenyl-2,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepines as 5-HT7/2 inhibitors leading to the identification of a clinical candidate. Bioorganic & Medicinal Chemistry Letters. 31. 127669–127669. 3 indexed citations
3.
Wang, Lien, Christine Dugovic, Sujin Yun, et al.. (2020). Putative role of GPR139 on sleep modulation using pharmacological and genetic rodent models. European Journal of Pharmacology. 882. 173256–173256. 2 indexed citations
4.
Fourgeaud, Lawrence, Curt A. Dvorak, Malika Faouzi, et al.. (2019). Pharmacology of JNJ-28583113: A novel TRPM2 antagonist. European Journal of Pharmacology. 853. 299–307. 27 indexed citations
5.
Nepomuceno, Diane, Chester Kuei, Curt A. Dvorak, et al.. (2018). Re-evaluation of Adrenocorticotropic Hormone and Melanocyte Stimulating Hormone Activation of GPR139 in Vitro. Frontiers in Pharmacology. 9. 157–157. 14 indexed citations
6.
Song, Jiao, Xuejun Liu, Jian Zhu, et al.. (2015). Polypharmacology of Small-Molecule Modulators of the 5-Lipoxygenase Activating Protein (FLAP) Observed via a High-throughput Lipidomics Platform. SLAS DISCOVERY. 21(2). 127–135. 4 indexed citations
7.
Liu, Changlu, Pascal Bonaventure, Grace Lee, et al.. (2015). GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids l-Tryptophan and l-Phenylalanine. Molecular Pharmacology. 88(5). 911–925. 54 indexed citations
8.
Dvorak, Curt A., Heather Coate, Diane Nepomuceno, et al.. (2015). Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 Receptor. ACS Medicinal Chemistry Letters. 6(9). 1015–1018. 30 indexed citations
9.
Shelton, Jonathan, Sujin Yun, Susan Losee Olson, et al.. (2015). Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activity. Frontiers in Behavioral Neuroscience. 8. 453–453. 10 indexed citations
10.
Tran, Da‐Thao, Pascal Bonaventure, Michael D. Hack, et al.. (2011). Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists. European Journal of Pharmacology. 667(1-3). 120–128. 25 indexed citations
11.
Swanson, Devin M., Jill A. Jablonowski, Chandra Shah, et al.. (2011). The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y2 receptor. Bioorganic & Medicinal Chemistry Letters. 21(18). 5552–5556. 13 indexed citations
12.
Dvorak, Curt A., Lisa Dvorak, Diane Nepomuceno, et al.. (2010). Novel tetrahydropyrido[3,2-c]pyrroles as 5-HT7 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(1). 42–44. 4 indexed citations
13.
Dvorak, Curt A., Richard L. Apodaca, Wei Xiao, et al.. (2009). Diamine-based human histamine H3 receptor antagonists: (4-Aminobutyn-1-yl)benzylamines. European Journal of Medicinal Chemistry. 44(10). 4098–4106. 10 indexed citations
14.
Shireman, Brock T., Curt A. Dvorak, Pascal Bonaventure, et al.. (2008). 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists. Bioorganic & Medicinal Chemistry Letters. 18(6). 2103–2108. 10 indexed citations
15.
Jablonowski, Jill A., Kiev S. Ly, Curt A. Dvorak, et al.. (2008). Novel imidazole-based histamine H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(3). 903–907. 7 indexed citations
16.
Letavic, Michael A., Ann Barbier, Curt A. Dvorak, & Nicholas I. Carruthers. (2006). 5 Recent Medicinal Chemistry of the Histamine H3 Receptor. Progress in medicinal chemistry. 44. 181–206. 36 indexed citations
17.
Dvorak, Curt A., et al.. (2005). Palladium-Catalyzed Coupling of Pyrazole Triflates with Arylboronic Acids. The Journal of Organic Chemistry. 70(10). 4188–4190. 48 indexed citations
18.
Sutton, Steven W., Xiaobing Li, Leah Aluisio, et al.. (2004). Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX2R) antagonists. Bioorganic & Medicinal Chemistry Letters. 14(16). 4225–4229. 52 indexed citations
19.
Jablonowski, Jill A., Cheryl A. Grice, Wenying Chai, et al.. (2003). The First Potent and Selective Non-Imidazole Human Histamine H4Receptor Antagonists. Journal of Medicinal Chemistry. 46(19). 3957–3960. 176 indexed citations
20.
Dvorak, Curt A., Claire Dufour, Seiji Iwasa, & Viresh H. Rawal. (1999). ChemInform Abstract: Rapid Synthesis of Di‐ and Triquinanes by Direct Reductive Fragmentation of Paterno—Buechi‐Derived Oxetanes.. ChemInform. 30(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026